vs
IM Cannabis Corp.（IMCC）与Tilray Brands, Inc.（TLRY）财务数据对比。点击上方公司名可切换其他公司
Tilray Brands, Inc.的季度营收约是IM Cannabis Corp.的21461.8倍（$217.5M vs $10.1K）。IM Cannabis Corp.净利率更高（-7.8% vs -20.7%，领先12.9%）
IM Cannabis Corp是一家跨国大麻企业，专注于医用及成人娱乐用大麻的种植、生产、分销与零售业务，核心市场覆盖北美、欧盟及以色列，旗下拥有多个大麻品牌，同时销售大麻衍生健康消费品。
Tilray Brands, Inc.是一家美国企业，主营医药、大麻生活方式产品以及包装消费品业务，公司注册于美国，总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务，同时在德国和葡萄牙拥有大麻种植基地。
IMCC vs TLRY — 直观对比
营收规模更大
TLRY
是对方的21461.8倍
$10.1K
净利率更高
IMCC
高出12.9%
-20.7%
损益表 — Q3 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $10.1K | $217.5M |
| 净利润 | $-790 | $-44.9M |
| 毛利率 | 22.7% | 26.4% |
| 营业利润率 | -6.9% | -10.2% |
| 净利率 | -7.8% | -20.7% |
| 营收同比 | — | 3.1% |
| 净利润同比 | — | 47.4% |
| 每股收益（稀释后） | — | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMCCTLRY
| Q4 25 | — | $217.5M | ||
| Q3 25 | $10.1K | $209.5M | ||
| Q2 25 | $8.8K | $224.5M | ||
| Q1 25 | — | $185.8M | ||
| Q4 24 | $11.8K | $210.9M | ||
| Q3 24 | $9.0K | $200.0M | ||
| Q2 24 | $10.8M | $229.9M | ||
| Q1 24 | $9.1K | $188.3M |
净利润IMCCTLRY
| Q4 25 | — | $-44.9M | ||
| Q3 25 | $-790 | $-322.0K | ||
| Q2 25 | $-4.4K | $-1.3B | ||
| Q1 25 | — | $-789.4M | ||
| Q4 24 | — | $-85.3M | ||
| Q3 24 | $-1.6K | $-39.2M | ||
| Q2 24 | $-2.5M | $-31.7M | ||
| Q1 24 | — | $-92.7M |
毛利率IMCCTLRY
| Q4 25 | — | 26.4% | ||
| Q3 25 | 22.7% | 27.4% | ||
| Q2 25 | 14.7% | 30.1% | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | 21.4% | 29.8% | ||
| Q2 24 | 5.7% | 35.8% | ||
| Q1 24 | 23.2% | 26.2% |
营业利润率IMCCTLRY
| Q4 25 | — | -10.2% | ||
| Q3 25 | -6.9% | 1.0% | ||
| Q2 25 | -46.7% | -643.1% | ||
| Q1 25 | — | -409.0% | ||
| Q4 24 | -236.7% | -20.0% | ||
| Q3 24 | 18.3% | -18.3% | ||
| Q2 24 | -19.5% | -7.2% | ||
| Q1 24 | 28.9% | -43.6% |
净利率IMCCTLRY
| Q4 25 | — | -20.7% | ||
| Q3 25 | -7.8% | -0.2% | ||
| Q2 25 | -49.9% | -566.9% | ||
| Q1 25 | — | -424.9% | ||
| Q4 24 | — | -40.5% | ||
| Q3 24 | -17.3% | -19.6% | ||
| Q2 24 | -23.4% | -13.8% | ||
| Q1 24 | — | -49.2% |
每股收益（稀释后）IMCCTLRY
| Q4 25 | — | $-0.41 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $7.26 | ||
| Q1 25 | — | $-8.69 | ||
| Q4 24 | — | $-0.99 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $291.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $1.6B |
| 总资产 | — | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMCCTLRY
| Q4 25 | — | $291.6M | ||
| Q3 25 | — | $264.8M | ||
| Q2 25 | — | $256.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | $630.0K | $252.2M | ||
| Q3 24 | — | $280.1M | ||
| Q2 24 | $511.0K | $260.5M | ||
| Q1 24 | — | $225.9M |
股东权益IMCCTLRY
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $2.3M | $3.5B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | $4.0M | $3.4B | ||
| Q1 24 | — | $3.4B |
总资产IMCCTLRY
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | — | ||
| Q4 24 | $28.6M | $4.2B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | $29.4M | $4.2B | ||
| Q1 24 | — | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.3K | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | $2.2K | — |
| 自由现金流率自由现金流/营收 | 21.6% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IMCCTLRY
| Q4 25 | — | $-8.5M | ||
| Q3 25 | $2.3K | $-1.3M | ||
| Q2 25 | — | $-12.8M | ||
| Q1 25 | — | $-5.8M | ||
| Q4 24 | $-786.2K | $-40.7M | ||
| Q3 24 | — | $-35.3M | ||
| Q2 24 | — | $30.7M | ||
| Q1 24 | $-4.4K | $-15.4M |
自由现金流IMCCTLRY
| Q4 25 | — | — | ||
| Q3 25 | $2.2K | — | ||
| Q2 25 | — | $-19.1M | ||
| Q1 25 | — | $-20.2M | ||
| Q4 24 | — | $-46.2M | ||
| Q3 24 | — | $-42.0M | ||
| Q2 24 | — | $21.0M | ||
| Q1 24 | $-4.7K | $-24.9M |
自由现金流率IMCCTLRY
| Q4 25 | — | — | ||
| Q3 25 | 21.6% | — | ||
| Q2 25 | — | -8.5% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | -21.9% | ||
| Q3 24 | — | -21.0% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | -51.7% | -13.2% |
资本支出强度IMCCTLRY
| Q4 25 | — | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | 3.3% | 5.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMCC
暂无分部数据
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |
